Article Details

Shattuck Labs Announces IND for SL-325 Is in Effect for the Treatment of Inflammatory ...

Retrieved on: 2025-08-21 15:15:19

Tags for this article:

Click the tags to see associated articles and topics

Shattuck Labs Announces IND for SL-325 Is in Effect for the Treatment of Inflammatory .... View article details on hiswai:

Excerpt

SL-325, a potentially first-in-class DR3 blocking antibody, is a fully Fc-silenced humanized immunoglobulin G monoclonal antibody, demonstrated ...

Article found on: www.theglobeandmail.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo